Pediatric Non-Wilms' Renal Tumors: a Third World Experience

Overview

Journal World J Surg

Publisher Wiley

Specialty General Surgery

Date 2012 Jan 25

PMID 22270981

Citations 7

Authors

Peter W Saula

G P Hadley

Affiliations

Soon will be listed here.

Abstract

Background: Pediatric non-Wilms' renal tumors (NWRT) are poorly understood owing to their heterogeneity and relative rarity. This study aimed at auditing the outcome of the management of NWRT in a tertiary hospital in the Third World.

Methods: Records of all patients (n = 68) treated for NWRT over a 32-year period (1978-2010) were reviewed retrospectively.

Results: The major histological groups included clear cell sarcoma of the kidney (CCSK) (33.8%), mesoblastic nephroma (17.6%), cystic partially differentiated nephroblastoma (CPDN) (17.6%), intrarenal neuroblastoma (8.8%), malignant rhabdoid tumor (MRT) (7.4%), and renal cell carcinoma (RCC) (5.9%). Sixteen (69.7%) patients with CCSK and 11 (91.7%) with CPDN were aged 1-4 years. Ten (83.3%) patients with mesoblastic nephroma were aged <1 year and three (60.0%) with RCC were aged 10-14 years. Ten (43.5%) patients with CCSK and four (80.0%) with RCC had metastases at diagnosis. The sensitivity of a pretreatment Tru-Cut biopsy was 100% for MRT. All the patients with CCSK, mesoblastic nephroma, CPDN, and RCC had radical nephrectomy. Only eight (34.8%) patients with CCSK received radiotherapy. The overall 1-10-year survival rates were 52.2%, 91.7%, 75.0%, 40.0% and 0.0% for CCSK, mesoblastic nephroma, CPDN, RCC, and MRT, respectively. The overall 1-10-year survival for the entire cohort was 51.5%.

Conclusions: The demography and clinical presentation of pediatric NWRT, which comprises 13.6% of pediatric renal tumors in the Third World, were similar to those in the Developed World. The overall 1-10-year survival for pediatric NWRT was low.

Citing Articles

Case report of an infant with congenital mesoblastic nephroma leading to pulmonary metastasis.

Athapathu A, Wijayawardhana S, Meegoda J, Gunaratne S, Somathilaka M, Chang K SAGE Open Med Case Rep. 2023; 11:2050313X231220826.

PMID: 38149118 PMC: 10750505. DOI: 10.1177/2050313X231220826.

Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of The Korean Pediatric Hematology and Oncology Group (KPHOG) Data.

Koh K, Han J, Choi H, Kang H, Lee J, Yoo K Cancer Res Treat. 2022; 55(1):279-290.

PMID: 35952715 PMC: 9873342. DOI: 10.4143/crt.2022.073.

Non-Wilms' renal tumors in children: experience with 139 cases treated at a single center.

Fang Y, Song H, Sun N, Zhang W BMC Urol. 2022; 22(1):89.

PMID: 35733141 PMC: 9219123. DOI: 10.1186/s12894-022-01042-3.

Imaging features and differences among the three primary malignant non-Wilms tumors in children.

Zhu Y, Fu W, Huang Y, Sun N, Peng Y BMC Med Imaging. 2021; 21(1):181.

PMID: 34847857 PMC: 8638146. DOI: 10.1186/s12880-021-00715-z.

Clinical and Molecular Characteristics and Outcome of Cystic Partially Differentiated Nephroblastoma and Cystic Nephroma: A Narrative Review of the Literature.

van Peer S, Pleijte C, de Krijger R, Jongmans M, Kuiper R, Lilien M Cancers (Basel). 2021; 13(5).

PMID: 33673661 PMC: 7957568. DOI: 10.3390/cancers13050997.

References

Perlman E . Pediatric renal tumors: practical updates for the pathologist. Pediatr Dev Pathol. 2005; 8(3):320-38. DOI: 10.1007/s10024-005-1156-7. View

Squire S, Chan M, Marcus K . Atypical teratoid/rhabdoid tumor: the controversy behind radiation therapy. J Neurooncol. 2006; 81(1):97-111. DOI: 10.1007/s11060-006-9196-z. View

Agrons G, Kingsman K, Wagner B . Rhabdoid tumor of the kidney in children: a comparative study of 21 cases. AJR Am J Roentgenol. 1997; 168(2):447-51. DOI: 10.2214/ajr.168.2.9016225. View

Hadley G, Sheik-Gafoor M . Clear cell sarcoma of the kidney in children: experience in a developing country. Pediatr Surg Int. 2010; 26(4):345-8. DOI: 10.1007/s00383-010-2554-0. View

Weeks D, Beckwith J, Mierau G, Luckey D . Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms' Tumor Study Pathology Center. Am J Surg Pathol. 1989; 13(6):439-58. View

Fidani P, De Ioris M, Serra A, De Sio L, Ilari I, Cozza R . A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience. J Neurooncol. 2008; 92(2):177-83. DOI: 10.1007/s11060-008-9750-y. View

Lowe L, Isuani B, Heller R, Stein S, Johnson J, Navarro O . Pediatric renal masses: Wilms tumor and beyond. Radiographics. 2000; 20(6):1585-603. DOI: 10.1148/radiographics.20.6.g00nv051585. View

Renshaw A . Pediatric renal cell carcinomas: where do they fit in the new histologic classification of renal cell carcinoma?. Adv Anat Pathol. 2000; 7(3):135-40. DOI: 10.1097/00125480-200007030-00001. View

VIDO L, Carli M, Rizzoni G, Calo L, Dalla Palma P, Parenti A . Congenital mesoblastic nephroma with hypercalcemia. Pathogenetic role of prostaglandins. Am J Pediatr Hematol Oncol. 1986; 8(2):149-52. View

10.

Sultan I, Qaddoumi I, Rodriguez-Galindo C, Al Nassan A, Ghandour K, Al-Hussaini M . Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors. Pediatr Blood Cancer. 2009; 54(1):35-40. DOI: 10.1002/pbc.22285. View

11.

Tomlinson G, Breslow N, Dome J, Guthrie K, Norkool P, Li S . Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor. J Clin Oncol. 2005; 23(30):7641-5. DOI: 10.1200/JCO.2004.00.8110. View

12.

Howell C, OTHERSEN H, Kiviat N, Norkool P, Beckwith J, DAngio G . Therapy and outcome in 51 children with mesoblastic nephroma: a report of the National Wilms' Tumor Study. J Pediatr Surg. 1982; 17(6):826-31. DOI: 10.1016/s0022-3468(82)80451-x. View

13.

Furtwaengler R, Reinhard H, Leuschner I, Schenk J, Goebel U, Claviez A . Mesoblastic nephroma--a report from the Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH). Cancer. 2006; 106(10):2275-83. DOI: 10.1002/cncr.21836. View

14.

Sebire N, Vujanic G . Paediatric renal tumours: recent developments, new entities and pathological features. Histopathology. 2008; 54(5):516-28. DOI: 10.1111/j.1365-2559.2008.03110.x. View

15.

Bruder E, Passera O, Harms D, Leuschner I, Ladanyi M, Argani P . Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol. 2004; 28(9):1117-32. DOI: 10.1097/01.pas.0000131558.32412.40. View

16.

Strouse J, Spevak M, Mack A, Arceci R, Small D, Loeb D . Significant responses to platinum-based chemotherapy in renal medullary carcinoma. Pediatr Blood Cancer. 2004; 44(4):407-11. DOI: 10.1002/pbc.20292. View

17.

Zhuge Y, Cheung M, Yang R, Perez E, Koniaris L, Sola J . Pediatric non-Wilms renal tumors: subtypes, survival, and prognostic indicators. J Surg Res. 2010; 163(2):257-63. DOI: 10.1016/j.jss.2010.03.061. View

18.

Glick R, Hicks M, Nuchtern J, Wesson D, Olutoye O, Cass D . Renal tumors in infants less than 6 months of age. J Pediatr Surg. 2004; 39(4):522-5. DOI: 10.1016/j.jpedsurg.2003.12.007. View

19.

Neumann H, Bender B, Berger D, Laubenberger J, Schultze-Seemann W, Wetterauer U . Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol. 1998; 160(4):1248-54. View

20.

BRUCE J, Gough D . Long-term follow-up of children with renal carcinoma. Br J Urol. 1990; 65(5):446-8. DOI: 10.1111/j.1464-410x.1990.tb14783.x. View